Darlix, Amélie
Louvel, Guillaume
Fraisse, Julien
Jacot, William
Brain, Etienne
Debled, Marc
Mouret-Reynier, Marie Ange
Goncalves, Anthony
Dalenc, Florence
Delaloge, Suzette
Campone, Mario
Augereau, Paule
Ferrero, Jean Marc
Levy, Christelle
Fumet, Jean-David
Lecouillard, Isabelle
Cottu, Paul
Petit, Thierry
Uwer, Lionel
Jouannaud, Christelle
Leheurteur, Marianne
Dieras, Véronique
Robain, Mathieu
Chevrot, Michaël
Pasquier, David
Bachelot, Thomas
Funding for this research was provided by:
This work was supported by R&D UNICANCER. The ESME MBC database is supported by an industrial consortium
Article History
Received: 27 June 2019
Revised: 10 October 2019
Accepted: 17 October 2019
First Online: 13 November 2019
Competing interests
: The authors declare no competing interests.
: The ESME MBC database was approved by an independent Ethics Committee (Comité De Protection des Personnes Sud-Est II-2015-79). No formal dedicated informed consent was required, but all patients had approved the use of their electronically recorded data. In compliance with the French regulations, the ESME MBC database was authorised by the French data protection authority (authorisation no. 1704113).
: This work was supported by R&D UNICANCER. The ESME MBC database receives financial support from an industrial consortium (Roche, Pfizer, AstraZeneca, MSD, Eisai and Daiichi Sankyo). Data collection, analysis and publication is managed entirely by R&D UNICANCER independently of the industrial consortium.
: Not applicable.
: The analysis data set will be made available upon request.